Discover opportunities months before the RFP drops
Learn more →Key metrics and characteristics
The city where this buyer is located.
The county where this buyer is located.
Physical address of this buyer.
Contact phone number for this buyer.
Postal code for this buyer's location.
How likely this buyer is to spend on new technology based on operating budget trends.
How likely this buyer is to adopt new AI technologies.
How often this buyer champions startups and early adoption.
Includes fiscal year calendars, procurement complexity scores, and strategic insights.
Active opportunities open for bidding
Pennsylvania Department of Health
The Commonwealth of Pennsylvania, through the Department of General Services for the Department of Health, is soliciting a vendor‑hosted SaaS solution to operate the ABC‑MAP Prescription Drug Monitoring Program (PDMP) in accordance with Act 191 of 2014. Proposals must be submitted electronically via the Commonwealth’s JAGGAER portal, and the base term is five years with five optional one‑year renewals. The scope is to support and enhance statewide PDMP operations to improve care by monitoring controlled‑substance prescriptions.
Posted Date
-
Due Date
Feb 6, 2026
Pennsylvania Department of Health
Close: Feb 6, 2026
The Commonwealth of Pennsylvania, through the Department of General Services for the Department of Health, is soliciting a vendor‑hosted SaaS solution to operate the ABC‑MAP Prescription Drug Monitoring Program (PDMP) in accordance with Act 191 of 2014. Proposals must be submitted electronically via the Commonwealth’s JAGGAER portal, and the base term is five years with five optional one‑year renewals. The scope is to support and enhance statewide PDMP operations to improve care by monitoring controlled‑substance prescriptions.
Pennsylvania Department of Health
Purchase of CD HIV Test Kits.
Posted Date
Dec 4, 2025
Due Date
Jan 9, 2026
Release: Dec 4, 2025
Pennsylvania Department of Health
Close: Jan 9, 2026
Purchase of CD HIV Test Kits.
Pennsylvania Department of Health
The Pennsylvania Department of Health is soliciting FDA‑approved, CLIA‑waived rapid HIV/syphilis combination tests and rapid hepatitis C tests (or a combination covering all three), including controls and micro readers, with direct shipment to a provider network. The one‑year contract (with two optional two‑year renewals) requires vendor‑provided virtual training and technical support; bids are due December 2, 2025 at 10:00 AM ET.
Posted Date
Nov 7, 2025
Due Date
Dec 2, 2025
Release: Nov 7, 2025
Pennsylvania Department of Health
Close: Dec 2, 2025
The Pennsylvania Department of Health is soliciting FDA‑approved, CLIA‑waived rapid HIV/syphilis combination tests and rapid hepatitis C tests (or a combination covering all three), including controls and micro readers, with direct shipment to a provider network. The one‑year contract (with two optional two‑year renewals) requires vendor‑provided virtual training and technical support; bids are due December 2, 2025 at 10:00 AM ET.
Get alerted before the bid drops, know which RFPs to pursue, and generate compliant drafts with AI.
Track vendor wins and renewal opportunities
Pennsylvania Department of Health
This Provider Agreement outlines the terms for ABC123 Family Health Practice to participate in the PA CARES program. The Department of Health provides AAP, ACOG, and AAFP recommended vaccines, not covered by the VFC program, for administration to eligible individuals aged 18 or younger who lack full vaccination insurance coverage. The agreement details patient screening, record-keeping, vaccine storage, administration fee caps ($23.14 per dose), and prohibits charging for the vaccines themselves. The contract term is ten years, commencing from the last Commonwealth signature date.
Effective Date
Nov 26, 2025
Expires
Effective: Nov 26, 2025
Pennsylvania Department of Health
Expires:
This Provider Agreement outlines the terms for ABC123 Family Health Practice to participate in the PA CARES program. The Department of Health provides AAP, ACOG, and AAFP recommended vaccines, not covered by the VFC program, for administration to eligible individuals aged 18 or younger who lack full vaccination insurance coverage. The agreement details patient screening, record-keeping, vaccine storage, administration fee caps ($23.14 per dose), and prohibits charging for the vaccines themselves. The contract term is ten years, commencing from the last Commonwealth signature date.
AvailablePennsylvania Department of Health
This is a Participating Provider Agreement (PPA No. 21006) between the Commonwealth of Pennsylvania Department of Health Chronic Renal Disease Program (CRDP) and Regional Health Services, Inc., effective December 1, 2021. The agreement outlines the provision of special health services, primarily dialysis and kidney transplant-related care, to CRDP-eligible individuals. It details service requirements, provider standards, payment mechanisms based on a fee schedule and authorized patient charges (coinsurance/deductibles), and billing procedures. The CRDP acts as the payer of last resort. The contract includes provisions for termination, suspension of services, and monitoring, incorporating standard general terms and conditions.
Effective Date
Dec 1, 2021
Expires
Effective: Dec 1, 2021
Pennsylvania Department of Health
Expires:
This is a Participating Provider Agreement (PPA No. 21006) between the Commonwealth of Pennsylvania Department of Health Chronic Renal Disease Program (CRDP) and Regional Health Services, Inc., effective December 1, 2021. The agreement outlines the provision of special health services, primarily dialysis and kidney transplant-related care, to CRDP-eligible individuals. It details service requirements, provider standards, payment mechanisms based on a fee schedule and authorized patient charges (coinsurance/deductibles), and billing procedures. The CRDP acts as the payer of last resort. The contract includes provisions for termination, suspension of services, and monitoring, incorporating standard general terms and conditions.
AvailablePennsylvania Department of Health
This contract, identified as IFB #67007, is between the Commonwealth of Pennsylvania, Department of Health, and Abbott Laboratories Inc. for the supply of infant formula and the provision of rebates under the Pennsylvania Special Supplemental Nutrition Program for Women, Infants and Children (WIC). The agreement is effective from October 1, 2023, to September 30, 2028, with a potential three-month extension. Abbott Laboratories Inc. was selected as the sole infant formula manufacturer, agreeing to provide rebates on its products, primarily Similac Advance and Similac Soy Isomil, as detailed in the Rebate Rate Schedule. The contract outlines terms for rebate calculation, wholesale price adjustments, product changes, and payment procedures.
Effective Date
Oct 1, 2023
Expires
Effective: Oct 1, 2023
Pennsylvania Department of Health
Expires:
This contract, identified as IFB #67007, is between the Commonwealth of Pennsylvania, Department of Health, and Abbott Laboratories Inc. for the supply of infant formula and the provision of rebates under the Pennsylvania Special Supplemental Nutrition Program for Women, Infants and Children (WIC). The agreement is effective from October 1, 2023, to September 30, 2028, with a potential three-month extension. Abbott Laboratories Inc. was selected as the sole infant formula manufacturer, agreeing to provide rebates on its products, primarily Similac Advance and Similac Soy Isomil, as detailed in the Rebate Rate Schedule. The contract outlines terms for rebate calculation, wholesale price adjustments, product changes, and payment procedures.
AvailableSee expiring contracts, renewal risk, pricing history, and competitor awards — then sync the data to your CRM.
Board meetings and strategic plans from Pennsylvania Department of Health
The meeting involved introductions and the approval of the August 2025 meeting minutes. The Board voted to approve a new Board Membership Pre-Application after requesting revisions, specifically to change the title and add contact information for assistance. Board Officer elections were held, with results pending announcement the following week. Key discussions included potential changes to the 2026 meeting dates due to venue unavailability, requiring a survey to determine the preferred virtual or in-person dates. Workgroup updates covered several initiatives: the Systems Workgroup is piloting brain injury training for substance use providers in Bucks County and attempting collaboration with the child welfare system; the Education and Resource Facilitation Workgroup is planning a concussion awareness poster contest pilot targeting middle schools; and the Board reviewed referral gaps for DOH brain injury programs, recommending a county-level referral map. The Board also discussed results from the Board Input Survey and findings from the statewide needs assessment initiative, which revealed widespread gaps in care coordination and provider knowledge. Under public comment, updates were provided on Medicaid waiver initiatives (Reentry Waiver and Community HealthChoices modification), Brain Injury Awareness Day plans, changes to PA ABLE Account eligibility, and a fundraising event. Finally, the upcoming February 2026 meeting date and location were reviewed.
This annual report details the progress of the 2023-2028 State Health Improvement Plan, a comprehensive five-year strategy to enhance the health and well-being of all Pennsylvanians and reduce health inequalities. The plan focuses on three overarching areas: improving health equity by addressing social determinants of health, reducing chronic disease risk factors and societal impact, and increasing access to culturally humble whole person care throughout the lifespan. The report highlights activities and achievements in 2024 towards these strategic goals.
The agenda for the multi-day virtual meeting included several key components. Discussions centered around the Integrated HIV Prevention and Care Plan Recommendations (Parts 1 and 2). Specific activities involved a Team Building Activity featuring HPG Positionality Statements and a Provider Spotlight on PAAR (Pittsburgh Action Against Rape). The meeting also included updates from various HPG Subcommittees (Evaluation, Intersectional and Innovation), Workgroup Updates (Employment, Protocols, Membership & Recruitment, CQI), a presentation on HIV Friendly Presentation techniques, and a session on Late HIV Diagnosis. The structure of future HPG meetings was also discussed.
The agenda for this meeting included welcome and introductions, bureau updates from the Department of Health (DOH) covering budget and staffing, and committee business such as appointments/reappointments and setting 2026 meeting dates. Discussions also covered updates from HRSA/ACMG and the PA Newborn Screening Health Committee. Specific technical topics included G6PD Screening/Reporting, updates from Revvity, and matters related to Lysosomal Storage Disorders/X-ALD/Met, Cystic Fibrosis, SMA, and Hematology, as well as discussion on new conditions. The meeting concluded with a public comment period.
The meeting included a welcome and introductions, followed by the approval of changes to the State Action Plan language concerning diversity, equity, and inclusion (DEI) due to a federal executive order. Discussions covered the upcoming Board Officer elections scheduled for November 2025, with nominations due by August 15, 2025. The board also addressed conducting unofficial virtual Round Tables twice a year to allow for public feedback. Presentations were given on the Blue Envelope Project, which relates to including emergency contacts in driver records via House Bill 1268, and an update on the Board Input Survey, which was reopened until September 8, 2025, due to low response rates. Workgroup updates detailed the renaming of the 'Health Equity' workgroup to 'Growth, Access, and Development (GAD)' and progress on a Board-specific application. Furthermore, updates were provided on federal funding changes, including the relocation of Administration for Community Living (ACL) programs, and the status of the Head Injury Program (HIP) waitlist. Public comments included information on a Brain Injury Awareness Event and the new PA CareKit.
Extracted from official board minutes, strategic plans, and video transcripts.
Track Pennsylvania Department of Health's board meetings, strategic plans, and budget discussions. Identify opportunities 6-12 months before competitors see the RFP.
Keep your public sector contacts fresh and actionable. No more stale data.
Premium
Win more deals with deep buyer insights
Decision Makers
Director, Division of Operations and Quality Assurance, Bureau of Laboratories (Pennsylvania Department of Health)
Director, Office of Drug Surveillance and Misuse Prevention
Premium
Access the largest public sector contact database